Prediction Market Odds Rise for Fed Rate Hike by July 2027 Salesforce Shares Decline on Soft Revenue Outlook Amid Persistent AI Disruption Concerns 25 Books That Defined the 20th Century Enduring Intellectual Property and Market Impact Toyota Enters Home Furniture Market with Repurposed Luxury Car Seats Gold Consolidation Tests Structural Bull Case Amid Market Uncertainty French Open Prize Money Dispute Top Players Curtail Media Duties in Protest HSDT Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter BLDP Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment SLB Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Despite Stable Revenue FMNB Q1 2026 Earnings Strong EPS Beat Drives Investor Attention Despite Slight Stock Dip NextEra Energy NEE Q1 2026 Earnings EPS Beats Estimates by 125 as Renewable and Regulated Segments Drive Performance Valmont Industries VMI Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Strength Heartbeam Inc Warrant BEATW Slumps 23 A Tight Trading Range at 007 Phreesia Inc PHR Holds Steady Near Support Amid Consolidation Western Alliance Bancorporation Holds Steady Near 7859 as Consolidation Continues SelectQuote SLQT Drops 566 to 100 Approaching Critical Support Blueport Acquisition BPAC Edges Higher Near Resistance A Test of Momentum Asbestos Found in Childrens Toys Sold in Britain Regulatory Gaps Exposed AGI Inc AGBK Q1 2026 Earnings Earnings Beat Fails to Lift Stock as Revenue Details Remain Sparse Lexeo Therapeutics LXEO Slips 229 as Stock Tests Key Support Levels Bakkt Q1 2026 Earnings Significant EPS Miss Amid Ongoing Operational Challenges CARL Q1 2026 Earnings Personal Surgery Specialist Beats EPS Estimates Stock Rises Upstream Bio UPB Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Edges Lower Ball Corporation Q1 2026 Earnings EPS Beats Estimates by Nearly 9 Amid Solid Operational Performance DXC Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 293 SFL Q1 2026 Earnings Monumental EPS Surprise Overshadowed by Share Decline NVNO Q3 2025 Earnings EPS Beat Signals Progress in Cost Management and Clinical Milestones